Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)-Reference-Cited by-同舟云学术

Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS)

Published:2015-02 Issue:2 Volume:63 Page:287-296
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Watson Rachael,Wearmouth Emma,McLoughlin Amy-Claire,Jackson Arthur,Ward Sophie,Bertram Paula,Bennaceur Karim,Barker Catriona E.,Pappworth Isabel Y.,Kavanagh David,Lea Susan M.,Atkinson John P.,Goodship Timothy H.J.,Marchbank Kevin J.

Funder

Kids Kidney Research

The Northern Counties Kidney Research Fund

Kidney Research UK

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference53 articles.

1. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype;Bresin;J. Am. Soc. Nephrol.,2013

2. Virus-like display of a neo-self antigen reverses B cell anergy in a B cell receptor transgenic mouse model;Chackerian;J. Immunol.,2008

3. Heterogeneity of nephritic factor and its identification as an immunoglobulin;Davis;Proc. Natl. Acad. Sci. U.S.A.,1977

4. Complement factor h autoantibodies and age-related macular degeneration;Dhillon;Invest. Ophthalmol. Vis. Sci.,2010

5. Autoantibodies against complement components and functional consequences;Dragon-Durey;Mol. Immunol.,2013

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tecnologías disruptivas como alternativa a la obtención de órganos y tejidos artificiales;Revista Colombiana de Bioética;2020-05-07

2. The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease;Clinical Reviews in Allergy & Immunology;2019-12-13

3. Children as Biomarker Orphans: Progress in the Field of Pediatric Biomarkers;The Journal of Pediatrics;2018-02

4. Anti-complement-factor H-associated glomerulopathies;Nature Reviews Nephrology;2016-07-25

5. A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL;Oncotarget;2015-10-03